Lisa J. Underland

https://assets.montefioreeinstein.org/profiles/images/Underland_Lisa_DO_2x.jpg

First Name

Lisa

Last Name

Underland

NPI

1598083974

Faculty ID

13753

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Elsevier Profile

EMR ID

57202

Is Open Scheduling

Off

Kristine E. Torres-Lockhart

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/0b28f080-c3c8-11eb-9ea2-7374238588d1.jpg

First Name

Kristine

Last Name

Torres-Lockhart

NPI

1023467115

Faculty ID

16568

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Provider Type

Primary Care

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">Kristine Torres-Lockhart, MD, FASAM is an Assistant Professor of Medicine in the Division of General Internal Medicine and Department of Psychiatry and Behavioral Sciences at Montefiore Medical Center and the Albert Einstein College of Medicine, as well as the founding director of the Addiction Consult Service at Montefiore's Weiler Hospital. She is Program Director of the Addiction Medicine Fellowship and Co-Director of the Addiction Medicine rotation for medical trainees. An addiction medicine and internal medicine physician, she leads the development and implementation of health system interventions to improve substance use disorder (SUD) care in acute care settings and transitions of care to post-acute and ambulatory care settings.</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><br />Dr. Torres-Lockhart provides SUD treatment, HIV/AIDS care, hepatitis C treatment, and general internal medicine care at several sites across Montefiore Medical Center, including a community health care center. She also actively teaches and supervises medical students, residents, and fellows. She is double board certified in addiction medicine and internal medicine and credentialed as an HIV specialist by the American Academy of HIV Medicine.&nbsp;<br /><br />Dr. Torres-Lockhart completed her fellowship training in addiction medicine at Montefiore Medical Center. Prior to arriving at Montefiore, she completed her residency training in internal medicine and primary care at Brigham and Women&rsquo;s Hospital in Boston, MA, where she also served as primary care chief medicine resident at the West Roxbury and Jamaica Plain Veterans Affairs Medical Centers. She received her undergraduate degree from Dartmouth College and her medical degree from the Geisel School of Medicine at Dartmouth. She is the PI for a HRSA training grant and co-PI for an OASAS training grant to lead the development of educational opportunities in building the addiction medicine workforce. She currently serves on the Board of Directors for the New York Society of Addiction Medicine previously as Communication Chair and now as Secretary.&nbsp;</p>

Research Areas

Research Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

Selected Publications

<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">Singh-Tan, S., <strong>Torres-Lockhart, K.</strong>, Jakubowski, A., Lu, T., Starrels, J., De Lima, P., Arnsten, J., Nahvi, S., Southern, W. (2023). Addiction Consult Service and Inpatient Outcomes Among Patients with Alcohol Use Disorder. &nbsp;/J Gen Intern Med/, 1-8. doi:10.1007/s11606-023-08202-7</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">Jakukowski, A., Singh-Tan, S., <strong>Torres-Lockhart, K</strong>., Nahvi, S., Stein, M., Fox, A. D., &amp; Lu, T. (2023). Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation. /Addict Sci Clin Pract, 18/(1), 31. doi:10.1186/s13722-023-00386-x</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">Calcaterra, S. L., Bottner, R., Martin, M., Englander, H., Weinstein, Z. M., Weimer, M. B., Lambert, E., Ronan, M., Huerta, S., Zaman, T., Ullal, M., Peterkin, A., <strong>Torres-Lockhart, K.</strong>, Buresh, M., O&rsquo;Brien, M., Synder, H., Herzig, S. J. (2022). Management of opioid use disorder, opioid withdrawal, and opioid overdose prevention in hospitalized adults: A systematic review of existing guidelines. /J Hosp Med, 17(9),/679-692/./doi:10.1002/jhm.12908</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><strong>Torres-Lockhart, K.</strong> E., Lu, T. Y., Weimer, M. B., Stein, M. R., &amp; Cunningham, C. O. (2022). Clinical Management of Opioid Withdrawal. /Addiction, 117/(9), 2540-2550. doi:10.1111/add.15818</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">Cunningham, C. O., Khalid, L., Deng, Y., <strong>Torres-Lockhart, K.</strong>, Masyukova, M., Thomas, S., Zhang, C., Lu, T. (2022). A comparison of office-based buprenorphine treatment outcomes in Bronx community clinics before versus during the COVID-19 pandemic. /J Subst Abuse Treat, 135/, 108641. doi:10.1016/j.jsat.2021.108641</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">Joseph, G., <strong>Torres-Lockhart, K.</strong>, Stein, M. R., Mund, P. A., &amp; Nahvi, S. (2021). Reimagining patient-centered care in opioid treatment programs: Lessons from the Bronx during COVID-19. /J Subst Abuse Treat, 122/, 108219. doi:10.1016/j.jsat.2020.108219</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">He, L., <strong>Torres-Lockhart, K.</strong>, Forster, N., Ramakrishnan, S., Greninger, P., Garnett, M. J., McDermott, U., Rothenberg, S.M., Benes, C.H., Ellisen, L. W. (2013). Mcl-1 and FBW7 control a dominant survival pathway underlying HDAC and Bcl-2 inhibitor synergy in squamous cell carcinoma. /Cancer Discov, 3/(3), 324-337. doi:10.1158/2159-8290.CD-12-0417</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">Ibrahim, Y. H., Garcia-Garcia, C., Serra, V., He, L., <strong>Torres-Lockhart, K</strong>., Prat, A., Anton, P., Cozar, P., Guzman, M., Grueso, J., Rodriguez, O., Calvo, M.T., Aura, C., Diez, O., Rubio, I.T., Perez, J., Rodon, J., Cortes, J., Ellisen, L.W., Scaltriti, M., Baselga, J. (2012). PI3K inhibition impairs BRCA1/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibition. /Cancer Discov, 2/(11), 1036-1047. doi:10.1158/2159-8290.CD-11-0348</p>

EMR ID

113089

Biography

<p>Kristine E. Torres-Lockhart, MD, FASAM, is Director, Addiction Medicine Fellowship Program at Montefiore Einstein, Founding Director, Addiction Consult Service at Weiler Hospital and Assistant Professor, General Internal Medicine and Psychiatry and Behavioral Sciences at our Albert Einstein College of Medicine. Dr. Torres-Lockhart is a general internist, primary care provider and addiction medicine specialist. She focuses on caring for people who use substances and people with substance use disorders, providing care in hospital settings and in outpatient clinics.</p><p>After obtaining her Bachelor of Arts in neuroscience from Dartmouth College in 2010, Dr. Torres-Lockhart earned her Doctor of Medicine at the Geisel School of Medicine at Dartmouth in 2016. She completed an internship and residency in internal medicine and primary care at Brigham and Women&rsquo;s Hospital in 2019. Following this, Dr. Torres-Lockhart completed a fellowship in addiction medicine at Montefiore Einstein in 2020.</p><p>Dr. Torres-Lockhart's research focuses on evidence-based and harm-reduction-oriented strategies for addressing substance use disorder care in acute care settings, integration of addiction medicine into medical education and optimizing transitions of care for people who use drugs. She has been principal investigator and co-investigator on funded research projects and her work has been published in numerous peer-reviewed publications. Dr. Torres-Lockhart has also shared her work through numerous invited presentations, abstracts and poster presentations. She is a reviewer for scientific journals, including Addiction Science and Clinical Practice, the Journal of Addiction Medicine, the Journal of Substance Abuse Treatment and the Journal of Hospital Medicine.</p><p>Dr. Torres-Lockhart is board certified by the American Board of Internal Medicine and the American Board of Preventive Medicine with certification in Addiction Medicine. She is a Fellow of the American Society of Addiction Medicine, board member of the New York Society of Addiction Medicine and member of the Association for Multidisciplinary Education and Research in Substance Use and Addiction. In 2022, Dr. Torres-Lockhart received the President&rsquo;s Award at the New York Society of Addiction Medicine&rsquo;s Annual Conference. In 2023, she received the Quality Improvement Champion honor at the United Hospital Fund's Tribute to Excellence in Health Care and was a Rising Star Nominee for the Department of Medicine&rsquo;s Physician Recognition Awards at Montefiore Einstein.</p>

Is Open Scheduling

Off

Gitit Tomer

https://assets.montefioreeinstein.org/profiles/images/Tomer_Gitit_MD_2x.jpg

First Name

Gitit

Last Name

Tomer

NPI

1295765618

Faculty ID

11963

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Languages

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p><span><span>Dr. Tomer is the director of the Pediatric Inflammatory Bowel Disease program at the Children's Hospital at Montefiore.&nbsp;</span></span>She is Associate Professor of Clinical Pediatrics. &nbsp;Dr. Tomer graduated from Sackler School of Medicine, Tel- Aviv, Israel. Dr. Tomer completed her Pediatric Residency at New York University School of Medicine and her Pediatric Gastroenterogy and Nutrition Fellowship at Mount Sinai Medical Center, New York. Dr Tomer was Assistant Professor of Pediatrics in the Division of Pediatric Gastroenterology at Cincinnati Children&rsquo;s Hospital for four years prior to joining the Pediatric GI Division at The Children&rsquo;s Hospital at Montefiore in 2009. Dr. Tomer&rsquo;s research interests include inflammatory bowel diseases, quality improvement work, and capsule endoscopy. &nbsp;</p>

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Elsevier Profile

PubMed.gov URL

Selected Publications

<p>1. Obtaining research biopsies during pediatric colonoscopy: Safety and adverse events. Mait-Kaufman J, Kahn S, Tomer G. World J Gastrointest Endosc. 2015 Jun 25;7(7):736-40. doi: 10.4253/wjge.v7.i7.736.</p>
<p>2.&nbsp; Improving Nonattendance at Outpatient Pediatric Endoscopy Unit of a Tertiary Center. Kogan-Liberman D, Rivas Y, Thompson J, Tomer G. J Pediatr Gastroenterol Nutr. 2015 Aug;61(2):234-7. doi: 10.1097/MPG.0000000000000791.</p>
<p>3. Improving the timeliness of procedures in a pediatric endoscopy suite. Tomer G, Choi S, Montalvo A, Sutton S, Thompson J, Rivas Y.&nbsp; Pediatrics. 2014 Feb;133(2):e428-33. doi: 10.1542/peds.2013-2316. Epub 2014 Jan 20.</p>
<p>4. Improved outcomes with quality improvement interventions in pediatric inflammatory bowel disease. Samson CM, Morgan P, Williams E, Beck L, Addie-Carson R, McIntire S, Booth A, Mendez E, Luzader C, Tomer G, Saeed S, Donovan E, Bucuvalas J, Denson LA. J Pediatr Gastroenterol Nutr. 2012 Dec;55(6):679-88. doi: 10.1097/MPG.0b013e318262de16.</p>
<p>5.Factors that determine risk for surgery in pediatric patients with Crohn's disease. Schaefer ME, Machan JT, Kawatu D, Langton CR, Markowitz J, Crandall W, Mack DR, Evans JS, Pfefferkorn MD, Griffiths AM, Otley AR, Bousvaros A, Kugathasan S, Rosh JR, Keljo DJ, Carvalho RS, Tomer G, Mamula P, Kay MH, Kerzner B, Oliva-Hemker M, Kappelman MD, Saeed SA, Hyams JS, Leleiko NS. Clin Gastroenterol Hepatol. 2010 Sep;8(9):789-94. doi: 10.1016/j.cgh.2010.05.021. Epub 2010 May 31.</p>
<p>&nbsp;6. Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity. Dotson JL, Hyams JS, Markowitz J, LeLeiko NS, Mack DR, Evans JS, Pfefferkorn MD, Griffiths AM, Otley AR, Bousvaros A, Kugathasan S, Rosh JR, Keljo D, Carvalho RS, Tomer G, Mamula P, Kay MH, Kerzner B, Oliva-Hemker M, Langton CR, Crandall W. J Pediatr Gastroenterol Nutr. 2010 Aug;51(2):140-5. doi: 10.1097/MPG.0b013e3181ca4db4.</p>
<p>7.&nbsp; Outcome following infliximab therapy in children with ulcerative colitis. Hyams JS, Lerer T, Griffiths A, Pfefferkorn M, Stephens M, Evans J, Otley A, Carvalho R, Mack D, Bousvaros A, Rosh J, Grossman A, Tomer G, Kay M, Crandall W, Oliva-Hemker M, Keljo D, LeLeiko N, Markowitz J; Pediatric Inflammatory Bowel Disease Collaborative Research Group. Am J Gastroenterol. 2010 Jun;105(6):1430-6. doi: 10.1038/ajg.2009.759. Epub 2010 Jan 26.</p>
<p>&nbsp;8. Polymorphisms in the IBD5 locus are associated with Crohn disease in pediatric Ashkenazi Jewish patients. Tomer G, Wetzler G, Keddache M, Denson LA. J Pediatr Gastroenterol Nutr. 2009 May;48(5):531-7. doi: 10.1097/MPG.0b013e318183138a.</p>
<p>9. Granulocyte-macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn's disease. Han X, Uchida K, Jurickova I, Koch D, Willson T, Samson C, Bonkowski E, Trauernicht A, Kim MO,Tomer G, Dubinsky M, Plevy S, Kugathsan S, Trapnell BC, Denson LA. Gastroenterology. 2009 Apr;136(4):1261-71, e1-3. doi: 10.1053/j.gastro.2008.12.046. Epub 2008 Dec 24.</p>
<p>10. Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Kugathasan S, Baldassano RN, Bradfield JP, Sleiman PM, Imielinski M, Guthery SL, Cucchiara S, Kim CE, Frackelton EC, Annaiah K, Glessner JT, Santa E, Willson T, Eckert AW, Bonkowski E, Shaner JL, Smith RM, Otieno FG, Peterson N, Abrams DJ, Chiavacci RM, Grundmeier R, Mamula P,Tomer G, Piccoli DA, Monos DS, Annese V, Denson LA, Grant SF, Hakonarson H. Nat Genet. 2008 Oct;40(10):1211-5. doi: 10.1038/ng.203. Epub 2008 Aug 31.</p>
<p>&nbsp;11. Genetic variants in the autophagy pathway contribute to paediatric Crohn's disease. Peterson N, Guthery S, Denson L, Lee J, Saeed S, Prahalad S, Biank V, Ehlert R, Tomer G, Grand R, Rudolph C, Kugathasan S. Gut. 2008 Sep;57(9):1336-7; author reply 1337. doi: 10.1136/gut.2008.152207. No abstract available.</p>
<p>&nbsp;12. Electronic clinical challenges and images in GI. Meckel's diverticulum. Zeisler B, Moyer SM, Farrell M, Collins MH, Tomer G. Gastroenterology. 2008 Apr;134(4):e3-4. doi: 10.1053/j.gastro.2008.02.039. No abstract available. Erratum in: Gastroenterology. 2008 Jul;135(1):326.</p>
<p>13.NOD2/CARD15 variants are associated with lower weight at diagnosis in children with Crohn's disease. Tomer G, Ceballos C, Concepcion E, Benkov KJ. Am J Gastroenterol. 2003 Nov;98(11):2479-84.</p>
<p>14. Disorders of bile formation and biliary transport. Tomer G, Shneider BL. Gastroenterol Clin North Am. 2003 Sep;32(3):839-55, vi. Review.</p>
<p>15. Differential developmental regulation of rat liver canalicular membrane transporters Bsep and Mrp2. Tomer G, Ananthanarayanan M, Weymann A, Balasubramanian N, Suchy FJ. Pediatr Res. 2003 Feb;53(2):288-94.</p>
<p>&nbsp;</p>
<p>&nbsp;</p>

EMR ID

5262

Biography

<p>Gitit Tomer, MD, is Director of the Pediatric Inflammatory Bowel Disease (IBD) Program at Children&rsquo;s Hospital at Montefiore (CHAM) and Professor of Pediatrics at our Albert Einstein College of Medicine. Dr. Tomer has been a member of the Montefiore team since 2009, with a clinical focus on inflammatory bowel disease, performance improvement and capsule endoscopy.</p><p>Dr. Tomer received her medical degree from Sackler School of Medicine, Tel-Aviv University, in 1995. She completed her Pediatric internship and residency at New York University School of Medicine in 1998, and went on to complete her Pediatric Gastroenterology and Nutrition fellowship at Mount Sinai Medical Center in 2001.</p><p>Dr. Tomer&rsquo;s focus on IBD, performance improvement and endoscopy extend to her research interests. She is the CHAM physician leader of ImproveCareNow, a national collaborative that champions improved care for children and youth with Crohn&rsquo;s disease and ulcerative colitis. Her research in pediatric IBD examines many facets, extending from the racial differences in initial presentation, early treatment and 1-year outcomes in pediatric Crohn&rsquo;s disease, to differences in satisfaction with work-life balance among pediatric gastroenterologists. Dr. Tomer&rsquo;s work has been published in a number of reviewed journals, books, review articles, and abstracts.</p><p>Dr. Tomer is board certified by the American Board of Pediatrics in Pediatric Gastroenterology. She is a member of the American Gastroenterological Association (AGA) and the Crohn's & Colitis Foundation of America (CCFA), and serves as the chair of the Professional Development Committee of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).</p>

Is Open Scheduling

Off

Alecia M. Thompson

https://assets.montefioreeinstein.org/profiles/images/Thompson_Alecia_MD_420x540.jpg

First Name

Alecia

Last Name

Thompson

NPI

1992930796

Faculty ID

12295

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

CHAM Provider

On

Professional Title

Research Focus

Dr. Thompson-Branch's research has focused on the role of cytokines in bronchopulmonary dysplasia and use of ultrasound to diagnose necrotizing enterocolitis.

Elsevier Profile

EMR ID

5397

Biography

<p>With an emphasis on general pediatrics and neonatology, Dr. Thompson completed her residency at NYU Medical Center in 2007 and fellowship at Yale-New Haven Hospital in 2010. During her fellowship, Dr. Thompson also audited the Robert Wood Johnson Clinical Scholars Program, with an interest in performing clinical research. Her research has focused on the role of cytokines in bronchopulmonary dysplasia and use of ultrasound to diagnose necrotizing enterocolitis. She plans to conduct research on the use of near-infrared spectroscopy to delineate central nervous system pathology in preterm infants and predict short-term neurologic outcomes.</p>

Is Open Scheduling

Off

John F. Thompson

https://assets.montefioreeinstein.org/profiles/images/Thompson_John_F_MD_2x.jpg

First Name

John

Last Name

Thompson

NPI

1104845023

Faculty ID

12044

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Elsevier Profile

EMR ID

5266

Biography

<!--Dr. Thompson completed his Pediatric Residency at the University of Chicago School of Medicine and his Pediatric Gastroenterology and Nutrition Fellowship at Babies Hospital/Columbia University. He was the Director of Pediatric Gastroenterology and Nutrition at the University of Miami Miller School of Medicine for 16 years prior to assuming the position of Chief of Pediatric Gastroenterology at The Children?s Hospital at Montefiore. He has earned an international reputation as a leader in the treatment of a full range of complex childhood gastrointestinal and liver conditions including Crohn?s disease, ulcerative colitis, celiac disease, short bowel syndrome, chronic abdominal pain and intestinal transplantation.--><p>John F. Thompson, MD, is Chief, Division of Pediatric Gastroenterology, Hepatology and Nutrition at Children's Hospital at Montefiore (CHAM) and Professor of Pediatrics at our Albert Einstein College of Medicine. Dr. Thompson specializes in short bowel syndrome, Crohn's disease, ulcerative colitis, celiac disease, eosinophilic esophagitis, feeding disorder, and chronic abdominal pain. </p><p>Dr. Thompson graduated from the College of the Holy Cross with a B.A. and M.S. in Chemistry. He was awarded his Doctor of Medicine from Loyola University Stritch School of Medicine in 1977. He completed a residency in Pediatrics at Wyler's Children's Hospital, University of Chicago Hospitals and Clinics in 1980, followed by a fellowship in Pediatric Gastroenterology and Nutrition at Babies Hospital, Columbia University Medical Center. Dr. Thompson was Chief of the Division of Pediatric Gastroenterology and Nutrition in the University of Miami Miller School of Medicine for 15 years before he was recruited to CHAM in 2009.</p><p>Under Dr. Thompson's leadership, the Division of Pediatric Gastroenterology, Hepatology and Nutrition at CHAM has shown remarkable growth and is now one of the premier programs in the country with expertise in inflammatory bowel disease, hepatology and liver transplantation, therapeutic endoscopy, intestinal failure, celiac disease, aerodigestive and eosinophilic gastrointestinal disorders. </p><p>Dr. Thompson is the director of the Intestinal Rehabilitation Program at CHAM. His research focuses on ways to improve the lives and outcomes of children who have intestinal failure and short bowel syndrome, with multiple active Institutional Review Board (IRB)-approved studies. He also is the Principal Investigator in two multicentered international clinical trials examining the effectiveness of teduglutide for the treatment of short bowel syndrome in children</p>

Is Open Scheduling

Off

Mark A. Thomas

https://assets.montefioreeinstein.org/profiles/images/Thomas_Mark_A_MD_420x504.jpg

First Name

Mark

Last Name

Thomas

NPI

1215021571

Faculty ID

6011

CMO Specialties

Clinical Terms

Employment Status

Per Diem

Patient Type

Adult

Department

Gender

Male

Email

Titles

Locations

Education and Trainings

Research Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

3524

Is Open Scheduling

Off

Peter L. Tenore

https://assets.montefioreeinstein.org/profiles/images/9816-tenore.jpg

First Name

Peter

Last Name

Tenore

NPI

1316063027

Faculty ID

9816

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Provider Type

Primary Care

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

Dr. Tenore is a Medical Director in the Division of Substance Abuse and is a wekk known figure in this field, having published in several journals and providing education in substance abuse to local and state agencies. He is an advisor to the New York State Ofice of Alcoholism and Substance Abuse Services and the federal Center for Substance Abuse Treatment. He is certified in Internal Medicine and by examination in Addiction Medicine and a New York State HIV Provider. His particular interests are management of cocaine and other addictions as well as providing hepatitis C and HIV treatment in the methadone clinic setting.

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

Selected Publications

DINO-VAMP: A Helpful Acronym in Determining Optimal Methadone Dosing and Brief review of Dosing Literature, Journal of Maintenance in the Addictions, Vol.2(4).

Guidance On Optimal Methadone Dosing, Addiction Treatment Forum, Vol.12 (2).

Methadone:A Medical Model in "Innovations in Substance Abuse Treatment and Policy," Yale University Center for Interdisciplinary Research, Yale Publicatinos, New Haven, CT.

Three Oral Formulations of Methadone: A Clinical and Pharmacodynamic Comparison, Journal of Substance Abuse Treatment, Vol. 17(3), Gourevitch, Hartell, Tenore, et al.

EMR ID

3901

Is Open Scheduling

Off

Ivy Tam

https://assets.montefioreeinstein.org/profiles/images/physphoto/Tam_Ivy_MD_420x504.jpg

First Name

Ivy

Last Name

Tam

NPI

1427494269

Faculty ID

15947

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Clinical Focus

Pediatric Medicine

Research Focus

Dr. Tam&rsquo;s research aims to improve care and communication for patients with limited English proficiency, as well as standardizing pain practices for children.&nbsp;

Elsevier Profile

EMR ID

14829

Biography

<p>Ivy Tam, MD, FAAP, is an Attending Physician and a Non-neonatal Emergency Transport Coordinator at Children&rsquo;s Hospital at Montefiore. She is also an Assistant Professor of Pediatrics at our Albert Einstein College of Medicine. </p><p>In 2009, Dr. Tam received her Bachelor of Arts in Biological Sciences at Cornell University. She then attended SUNY Upstate Medical University, where she received her Doctor of Medicine in 2013. Dr. Tam began her postgraduate training with a residency in pediatrics at New York University School of Medicine, followed by a fellowship in pediatric hospital medicine in 2018 at the University of California San Diego. </p><p>Dr. Tam&rsquo;s research aims to improve care and communication for patients with limited English proficiency, as well as standardizing pain practices for children. She has shared her work through presentations in academic forums and scientific meetings, and is currently in the process of being submitted for publication. </p><p>2017, Dr. Tam received the CARES Award from hospital staff at Rady Children&rsquo;s Hospital for her support during the medical director&rsquo;s absence. Dr. Tam is board certified by the American Board of Pediatrics and is a member of the American Academy of Pediatrics. </p>

Is Open Scheduling

Off

Hina J. Talib

https://assets.montefioreeinstein.org/profiles/images/Talib_Hina_MD_420x504-1.jpg

First Name

Hina

Last Name

Talib

NPI

1306005418

Faculty ID

12509

CMO Specialties

Clinical Terms

Employment Status

Voluntary

Patient Type

Pediatric

Department

Gender

Female

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Hina J. Talib, a Brown University&nbsp;<em>summa cum laude</em>&nbsp;graduate, earned her&nbsp;<em>Bachelor of Science</em>&nbsp;in Neuroscience. She attended medical school at Weill Cornell Medical College, NY where she served as vice-president of her class. She completed her Pediatrics Residency at New York Presbyterian- Weill Cornell and her Chief Residency in Pediatrics at Memorial Sloan Kettering Cancer Center.</p>
<p>Dr. Talib completed a three-year postdoctoral fellowship in Adolescent Medicine in June 2013 at The Children's Hospital at Montefiore. Dr. Talib joined CHAM as Assistant Medical Director for the Michael I. Cohen, MD Adolescent Inpatient Floor where she serves as a teaching hospitalist and chaired the Quality Improvement Committee. In 2015, Dr. Talib was appointed as Associate Director of the Adolescent Medicine Fellowship Training Program. In 2018, Dr. Talib was appointed Medical Director of the Adolescent Inpatient floor.&nbsp;</p>
<p>In addition to providing outpatient sub-specialty care at CHAM, Dr. Talib also cared for youth in foster care at the Children's Aid Society's Bronx Family Health Center. Dr. Talib offers Nexplanon dermal implants, as a method of long acting hormonal contraception, for teen pregnancy prevention at both sites. Her clinical interests include adolescent health, pediatric and adolescent gynecology, contraception, mental health, care of children in foster care, and care of the hospitalized adolescent.</p>
<p>Dr. Talib is board-certified in Pediatrics and in Adolescent Medicine. She is a Fellow of the American Academy of Pediatrics (AAP), and a member of the Society for Adolescent Health and Medicine (SAHM) and the North American Society for Pediatric and Adolescent Gynecology (NASPAG). She serves as Associate Editor of the <em>Journal of Pediatric and Adolescent Gynecology</em>, the official journal of NASPAG, and as a co-chair of the NASPAG resident education committee. In addition, Dr. Talib is a recent past President of the Executive Board of the New York chapter of SAHM.</p>
<p>Dr Talib currently provies pediatric and adolescent medicine care at the Atria Institute.&nbsp;</p>
<p>Connect with Dr. Talib at her website drhinatalib.com or follow Dr. Talib at her instagram @teenhealthdoc.&nbsp;</p>

Research Areas

Research Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Dr. Talib's clinical focus is adolescent health, pediatrics and adolescent gynecology, contraception, mental health, care of children in foster care and care of hospitalized adolescents.

Research Focus

Dr. Talib has been studying the effects of Vitamin D deficiency in the adolescent age group since 2012. In 2013, she published a study on influences of partner and relationship factors in HIV testing in Bronx youth. Through her work on the CHAM HIV Testing Task Force, she is currently conducting a quality improvement intervention to increase HIV testing in hospitalized adolescents.

Elsevier Profile

Selected Publications

<p><strong>Talib HJ,</strong> Coupey SM. Excessive Uterine Bleeding. <em>Adolesc Med</em> 2012; 23:53-72</p>
<p><strong>Talib HJ</strong>, Alderman EM.Gynecologic and Reproductive Health Concerns of Adolescents Using Selected Psychotropic Medications. <em>J Pediatr Adolesc Gynecol </em>2013; 26(1):7-15</p>
<p><strong>Talib HJ,</strong> Silver EJ, Coupey SM, Bauman LJ. The influence of individual, partner, and relationship factors in HIV testing in adolescents. <em>AIDS Patient Care STDs</em> 2013; 27(11): 637-4</p>
<p><strong>Talib HJ</strong>, Ponnapakkam T, Gensure R, Cohen HW, Coupey SM. Treatment of vitamin D deficiency in predominantly Hispanic and black adolescents: a randomized clinical trial. <em>J Pediatr</em> 2016; 170:266-72. PMID: 26707619</p>
<p><strong>Talib HJ</strong><span style="text-decoration: underline;">,</span> Silver EJ, Alderman EM. Challenges to adolescent confidentiality in a children&rsquo;s hospital. <em>Hosp Pediatr</em> 2016; 6(8):490-5. PMID: 27461762</p>
<p>Fleming N, Aimes-Oeschlager A, Browner-Elhanan KJ, Kaul P, <strong>Talib HJ</strong>, Wheeler C, Loveless M. Resident Education Curriculum in Pediatric and Adolescent Gynecology: The Short Curriculum. <em>J Pediatr Adolesc Gynecol </em>2014; 27(2):117-20</p>
<p><strong>Talib HJ</strong>, Karjane N, Teelin K, Abraham M, Holt S, Chelvakumar G, Dumont T, Huguelet PS, Connor L, Wheeler C, Fleming N. Resident education curriculum in pediatric and adolescent gynecology: the short curriculum 2.0. <em>J Pediatr Adolesc Gynecol</em>&nbsp;2018; 31(2):71-76</p>
<p>Bhalakia AM, <strong>Talib HJ</strong>, Choi J, Watnick D, Bochner R, Futterman D, Gross E. Acceptance of routine HIV testing by hospitalized adolescents and young adults. <em>Hospital Pediatr</em> 2018; 8(4):187-193. PMID:29599198</p>

Biography

<p>Hina J. Talib, MD, is Director of the Adolescent Medicine Fellowship Program and an Attending Physician in the Division of Adolescent Medicine at Children&rsquo;s Hospital at Montefiore. Dr. Talib is also an Associate&nbsp;Professor of Pediatrics at our Albert Einstein College of Medicine. Her clinical focus is adolescent health, pediatrics and adolescent gynecology, contraception, mental health, care of children in foster care and care of hospitalized adolescents. She joined the Montefiore team in 2013.</p><p>Dr. Talib received her Bachelor of Science in Neuroscience in 2001 from Brown University. In 2006, she received her Doctor of Medicine from Weill Cornell Medical College of Cornell University. In 2009, Dr. Talib completed a residency in pediatrics at New York Presbyterian Phyllis and David Komansky Center for Children&rsquo;s Health &ndash; Weill Cornell Medical Center. She became Chief Resident in Pediatrics at Memorial Sloan Kettering Cancer Center that same year. Dr. Talib went on to complete a postdoctoral fellowship in Adolescent Medicine at CHAM in 2013.</p><p>Dr. Talib has been studying the effects of Vitamin D deficiency in the adolescent age group since 2012. In 2013, she published a study on influences of partner and relationship factors in HIV testing in Bronx youth. Through her work on the CHAM HIV Testing Task Force, she is currently conducting a quality improvement intervention to increase HIV testing in hospitalized adolescents. Her work has been published numerous times in peer reviewed journals, review articles, and books and has been presented at national meetings.</p><p>In 2014, Dr. Talib won Best Platform Presentation for her work, &ldquo;Randomized Clinical Trial of Two High-dose vs. Low-dose Treatment Regimens for Vitamin D Deficiency in Minority Adolescents Living in a Northeast City&rdquo; at Pediatric Research Day at CHAM.</p><p>Dr. Talib is board certified by the American Board of Pediatrics and is a member of the American Academy of Pediatrics, Section in Adolescent Health.</p>

Is Open Scheduling

Off

Adit L. Tal

https://assets.montefioreeinstein.org/profiles/images/physphoto/Tal_Adit_MD_420x504.jpg

First Name

Adit

Last Name

Tal

NPI

1922445972

Faculty ID

16130

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Elsevier Profile

EMR ID

56692

Biography

<p>Adit Tal, MD, is an Attending Physician at Children&rsquo;s Hospital at Montefiore Einstein (CHAM) and an Assistant Professor of Pediatric Hematology, Oncology, Marrow and Blood Cell Transplantation at our Albert Einstein College of Medicine. Since joining the Montefiore team, Dr. Tal&rsquo;s clinical focus has been the treatment of pediatric leukemia and lymphoma, and the supportive care of children with cancer.</p><p>Dr. Tal received her Bachelor of Arts in Neuroscience from Johns Hopkins University in 2008, followed by her Doctorate of Medicine at the Sackler School of Medicine. She began her postgraduate training in 2013 at CHAM and Albert Einstein College of Medicine, following her Pediatrics residency with a Pediatric Hematology/Oncology fellowship.</p><p>Building on her clinical practices, Dr. Tal&rsquo;s research focuses on novel therapeutic targets for advanced treatments in metastatic osteosarcoma. She is examining a signaling pathway crucial to bone development and differentiation, and targeting this pathway to treat osteosarcoma. Her work has been published in numerous peer-reviewed articles.</p><p>Dr. Tal is board certified by the American Board of Pediatrics and is a member of many professional societies including the American Academy of Pediatrics, the Children&rsquo;s Oncology Group, and the American Society of Clinical Oncology. She is also a member of the Professional Development Committee with the American Society of Pediatric Hematology/Oncology, and is a volunteer pediatric oncologist at Happiness Is Camping, a residential camp for children with cancer and their families.</p>

Is Open Scheduling

Off